Paid Clinical Trials Toronto

Discover 2,007 paid clinical trials in Toronto, Ontario. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter

Filter results

Results: 2,007

Norovirus Research for Adults

Recruiting

Phase 3

Sponsor:

Moderna

Location:

Toronto, Guelph, Rochester, Londonshow 151 more

Code:

NCT06592794

Conditions

Acute Gastroenteritis

Norovirus Acute Gastroenteritis

Eligibility Criteria

Sex: All

Age: 60+

Healthy Volunteers: Accepted

Interventions

mRNA-1403

Placebo

Role of Epicardial Adipose Tissue in Coronary Artery Disease

Recruiting

Sponsor:

Hamilton Health Sciences Corporation

Location:

Hamilton

Code:

NCT00279227

Conditions

Coronary Artery Disease

Obesity

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Team Approach to Polypharmacy Evaluation and Reduction

Recruiting

Sponsor:

McMaster University

Location:

Hamilton

Code:

NCT02942927

Conditions

Multi-morbidity

Medication Therapy Management

Polypharmacy

Eligibility Criteria

Sex: All

Age: 70+

Healthy Volunteers: Not accepted

Interventions

Medication reduction

The Effects of Stress on the Clinical Performance of Residents in Simulated Trauma Scenarios

Recruiting

Sponsor:

University of Toronto

Location:

Toronto

Code:

NCT00485927

Conditions

Trauma

Stress

Eligibility Criteria

Sex: All

Age: 21 - 50

Healthy Volunteers: Not accepted

Interventions

stress

Endovascular Therapy for Low NIHSS Ischemic Strokes

Recruiting

PHASE2

PHASE3

Sponsor:

Emory University

Location:

Toronto, Mississauga, Buffalo, Londonshow 32 more

Code:

NCT04167527

Conditions

Cerebral Ischemia

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Immediate mechanical thrombectomy(iMT) using EmboTrap Revascularization Device

Initial medical management (iMM)

Open-Label Extension Study of Marstacimab in Hemophilia Participants With or Without Inhibitors

Recruiting

PHASE3

Sponsor:

Pfizer

Location:

Hamilton, New Hyde Park, Iowa City, Edmontonshow 1 more

Code:

NCT05145127

Conditions

Hemophilia A

Hemophilia B

Eligibility Criteria

Sex: Male

Age: 1 - 70+

Healthy Volunteers: Not accepted

Interventions

PF-06741086

NG101 AAV Gene Therapy in Subjects With Wet Age-Related Macular Degeneration

Recruiting

PHASE1

PHASE2

Sponsor:

Neuracle Genetics, Inc

Location:

Toronto, Cincinnati, Vancouver

Code:

NCT05984927

Conditions

Age-Related Macular Degeneration

Eligibility Criteria

Sex: All

Age: 50 - 70+

Healthy Volunteers: Not accepted

Interventions

NG101 AAV gene therapy

Safety and Efficacy Study of ICXP007 With Compression Bandaging for the Treatment of Non-Infected Venous Leg Ulcers

Recruiting

PHASE3

Sponsor:

Intercytex

Location:

Toronto, Mississauga, Oakville, Wellandshow 34 more

Code:

NCT00232973

Conditions

Leg Ulcer

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

ICXP007

The Anti-Diabetic and Cholesterol-Lowering Effects of Cinnamon and Cassia Bark

Recruiting

PHASE2

Sponsor:

University Health Network, Toronto

Location:

Toronto

Code:

NCT00479973

Conditions

Type 2 Diabetes

Hypercholesterolemia

Eligibility Criteria

Sex: All

Age: 30 - 70+

Healthy Volunteers: Not accepted

Interventions

Cinnamonforce

Placebo

A Pilot Study of SurVaxM in Children Progressive or Relapsed Medulloblastoma, High Grade Glioma, Ependymoma and Newly Diagnosed Diffuse Intrinsic Pontine Glioma

Recruiting

PHASE1

Sponsor:

Pediatric Brain Tumor Consortium

Location:

Toronto, Buffalo, Pittsburgh, New Yorkshow 8 more

Code:

NCT04978727

Conditions

Medulloblastoma

Glioblastoma Multiforme

Anaplastic Astrocytoma

High-grade Astrocytoma NOS

Anaplastic Oligodendroglioma

Eligibility Criteria

Sex: All

Age: 1 - 21

Healthy Volunteers: Not accepted

Interventions

SurVaxM for patients with relapsed or progressive MB, HGG or ependymoma ages ≥10 and ≤21 years

SurVaxM for patients with relapsed or progressive MB, HGG or ependymoma ages ≥1 and <10 years

SurVaxM for patients with non-relapsed DIPG post radiation-therapy ages ≥1 and ≤21 years

Paclitaxel and Ramucirumab +/- Zanidatamab in HER2 Postive Advanced Gastroesophageal Adenocarcinoma

Recruiting

PHASE2

Sponsor:

Canadian Cancer Trials Group

Location:

Toronto, Oshawa, Kitchener, Londonshow 8 more

Code:

NCT06043427

Conditions

Gastroesophageal Adenocarcinoma

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Paclitaxel

Ramucirumab

Zanidatamab